NO20042660L - Fremgangsmate til a behandle bakterielle infeksjoner ved a bruke gemifloksasin eller et salt derav og karbapenem antibakterielt middel - Google Patents

Fremgangsmate til a behandle bakterielle infeksjoner ved a bruke gemifloksasin eller et salt derav og karbapenem antibakterielt middel

Info

Publication number
NO20042660L
NO20042660L NO20042660A NO20042660A NO20042660L NO 20042660 L NO20042660 L NO 20042660L NO 20042660 A NO20042660 A NO 20042660A NO 20042660 A NO20042660 A NO 20042660A NO 20042660 L NO20042660 L NO 20042660L
Authority
NO
Norway
Prior art keywords
gemifloxacin
salt
bacterial infections
antibacterial agent
treating bacterial
Prior art date
Application number
NO20042660A
Other languages
English (en)
Other versions
NO331599B1 (no
Inventor
Nancy Niconovich
Stephen Rittenhouse
Lynn Mccloskey
Kyong-Sook Pack
Mu-Yong Kim
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of NO20042660L publication Critical patent/NO20042660L/no
Publication of NO331599B1 publication Critical patent/NO331599B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20042660A 2001-11-30 2004-06-24 Anvendelse av gemiflokasasin eller et salt derav og et karbapenem antibakterielt middel for fremstilling av et medikament til behandling av bakterielle infeksjoner, og sett inneholdende det samme NO331599B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33513101P 2001-11-30 2001-11-30
PCT/KR2002/002247 WO2003045389A1 (en) 2001-11-30 2002-11-29 A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent

Publications (2)

Publication Number Publication Date
NO20042660L true NO20042660L (no) 2004-06-24
NO331599B1 NO331599B1 (no) 2012-02-06

Family

ID=23310394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042660A NO331599B1 (no) 2001-11-30 2004-06-24 Anvendelse av gemiflokasasin eller et salt derav og et karbapenem antibakterielt middel for fremstilling av et medikament til behandling av bakterielle infeksjoner, og sett inneholdende det samme

Country Status (13)

Country Link
US (1) US20050020567A1 (no)
EP (1) EP1458390B1 (no)
AT (1) ATE404197T1 (no)
AU (1) AU2002360216A1 (no)
CA (1) CA2468033C (no)
CY (1) CY1108472T1 (no)
DE (1) DE60228324D1 (no)
DK (1) DK1458390T3 (no)
ES (1) ES2312654T3 (no)
MX (1) MXPA04005178A (no)
NO (1) NO331599B1 (no)
PT (1) PT1458390E (no)
WO (1) WO2003045389A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090018111A1 (en) * 2004-10-08 2009-01-15 Makoto Sunagawa Novel Antimicrobial Medicament
US9292565B2 (en) * 2010-06-30 2016-03-22 International Business Machines Corporation Template-based recognition of food product information

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080757A (en) * 1996-06-06 2000-06-27 Pfizer Inc Antibiotic quinolones and derivatives
WO2001095876A1 (en) * 2000-06-09 2001-12-20 Baylor College Of Medicine The combination of antimicrobial agents and bacterial interference to coat medical devices

Also Published As

Publication number Publication date
EP1458390A4 (en) 2007-07-04
CY1108472T1 (el) 2014-04-09
WO2003045389A1 (en) 2003-06-05
CA2468033C (en) 2008-02-12
DK1458390T3 (da) 2008-12-15
ATE404197T1 (de) 2008-08-15
US20050020567A1 (en) 2005-01-27
MXPA04005178A (es) 2004-08-11
ES2312654T3 (es) 2009-03-01
CA2468033A1 (en) 2003-06-05
EP1458390A1 (en) 2004-09-22
EP1458390B1 (en) 2008-08-13
DE60228324D1 (de) 2008-09-25
AU2002360216A1 (en) 2003-06-10
NO331599B1 (no) 2012-02-06
PT1458390E (pt) 2008-10-02

Similar Documents

Publication Publication Date Title
NO20042271L (no) Formuleringer som inneholder en cefalosporinforbindelse og deres anvendelse for behandling av bakterielle infeksjoner i katter og hunder
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
NO20055722D0 (no) Antiseptiske preparater, fremgangsmater og systemer
TW200507841A (en) Antibacterial agents
DE60334016D1 (de) Antibakterielle mittel
PT759774E (pt) Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico
AU2002368274A1 (en) Methods of treating infection by drug resistant bacteria
WO2005046579A3 (en) Defined dose therapeutic phage
AU2003303956A8 (en) Antibacterial agents
ATE354585T1 (de) Antibakterielle amid-makrozyklen
DE60225590D1 (de) C-kithemmer zur behandlung von bakteriellen infektionen
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
WO2003061704A3 (en) Combination therapy for the treatment of bacterial infections
DK1309336T3 (da) Laspartomycin-derivater og fremstilling og anvendelse deraf
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
AU2002353774A1 (en) Products and methods for treating microbial infections
NO20042660L (no) Fremgangsmate til a behandle bakterielle infeksjoner ved a bruke gemifloksasin eller et salt derav og karbapenem antibakterielt middel
DE60137459D1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
NO20062229L (no) Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er)
DK1439840T3 (da) Antibakterielle monobactam-forbindelser og fremgangsmåder til anvendelse heraf
WO2005080549A3 (de) Trioxacarcine und deren verwendung gegen infektionskrankheiten
EP1482958A4 (en) TECHNIQUE FOR TREATING, PREVENTING OR INHIBITING ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) INFECTIONS WITH BOVINE ERYTHROCYTE PREPARATIONS
AUPR916101A0 (en) Method of treating halitosis

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees